Assembly Biosciences, Inc. (ASMB)
32.29
-0.29
(-0.89%)
USD |
NASDAQ |
Dec 18, 11:20
Assembly Biosciences Research and Development Expense (Annual): 55.80M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Arvinas, Inc. | 348.20M |
| Supernus Pharmaceuticals, Inc. | 106.36M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |